Sunrest Lifescience Limited IPO : Key Information

Sunrest Lifescience Limited IPO is set to launch on 7 November, 2023. The company initiated its business operations in the year 2017. It is engaged in the business of personal care and healthcare products. The product portfolio includes tablets, Capsules, Syrups, Gel, Ointment, Solution, Mouthwash, Dry Powders, Suspension, Toothpaste etc. The drugs offered by the company are of extensive ranges like Antifungal, Antibacterial, Multimineral, Multivitamin, Anti-inflammatory, Nutraceutical, Cosmetic, AntiHistamine, Anti Protozoal, Dental Cure, Anti Parasitic etc. The company has 43 third party manufacturers for its drugs across states like Gujarat, Maharashtra, Punjab, Himachal Pradesh, Haryana, Madhya Pradesh, Uttarakhand etc. Sunrise Lifescience has a total of 32 products and 18  registered trademarks. 

Sunrest Lifescience Limited IPO DETAILS

Sunrest Lifescience Limited IPO is set to launch on 7 November, 2023. The subscription timeline extends till 9 November, 2023. The size for the IPO is 10.85 Crore Rs. Shares issued through fresh issue mode are worth 10.85 Crore Rs. No shares are issued through offer for sale mode. The lot size is 1600 shares and the price is 84 Rs per share. The company is going to get listed at NSE SME. The face value per share is Rs.10 and this is a Fixed Price issue. The registrar for the company is Skyline Financial Services Limited.

Tabular Description of Sunrest Lifescience Limited IPO 

IPO OPENING DATE 7 November, 2023
CLOSING DATE FOR IPO 9 November, 2023
ISSUE TYPE Fixed Price Issue
Face Value per share 10 Rs. per share
IPO price band 84 Rs per share
LOT SIZE 1600 shares
MINIMUM ORDER QUANTITY 1600 shares
ISSUE SIZE 10.85 Crore Rs.
OFFER FOR SALE No shares are issued through offer for sale mode
FRESH ISSUE 10.85 Crore Rs.
LISTING AT NSE SME
LISTING DATE 20 November, 2023

Sunrest Lifescience Limited IPO : IMPORTANT DATES

IPO OPENING DATE 7 November, 2023
CLOSING DATE FOR IPO 9 November, 2023
IPO ALLOTMENT DATE 15 November, 2023
REFUNDS 16 November, 2023
DEMAT A/C CREDITED ON 17 November, 2023
IPO LISTING DATE 20 November, 2023

Sunrest Lifescience Limited IPO begins for subscription from 7 November, 2023. The IPO subscription would continue till 9 November, 2023. The allotment status for the shareholders who applied would come on 15 November, 2023. The refunds for the ones who did not get allotment would be initiated on 16 November, 2023. The DEMAT accounts of shareholders would be credited on 17 November, 2023. The listing of the company would be completed on 20 November, 2023.

Sunrest Lifescience Limited IPO : Lead Managers

The lead managers are :

  • Mark Capital Advisors Private Limited

The minimum lot size for the company is decided at 1600 shares. This holding accounts to 134400 Rs.. The maximum lot size is decided at 1600 shares (HNI). This amounts to 134400 Rs.. Hence the company’s final holdings would be set as :

  Shares Amount
Minimum 1600 shares 134400 Rs.
Maximum 1600 shares 134400 Rs.

OBJECTIVES FOR THE IPO

  • IPO proceeds would be used for general corporate purposes.
  • The company will use the IPO money for further working capital requirements.

COMPANY FINANCIALS

Particularly (in Lakh Rs.) 2020-21 2021-22 2022-23
ASSETS 948 1301 1671
Revenue 1649 2690 2467
PAT 16 77 204

Sunrest Lifescience Limited had an asset base of 948 Lakh Rs in 2021 which increased to 1301 Lakh Rs in 2022 and 1671 Lakh Rs in 2023. The revenue of the firm was 1649 Lakh Rs in 2021 which increased to 2690 Lakh Rs in 2022. However in the year 2023 the revenue decreased to 2467 Lakh Rs. The profit of the firm was 16 Lakh Rs in the year 2021 which increased to 77 Lakh Rs in 2022. The profit of the firm was 204 Lakh Rs in the year 2023.

PROS

  • The product portfolio includes tablets, Capsules, Syrups, Gel, Ointment, Solution, Mouthwash, Dry Powders, Suspension, Toothpaste etc. 
  • The drugs offered by the company are of extensive ranges like Antifungal, Antibacterial, Multimineral, Multivitamin, Anti-inflammatory, Nutraceutical, Cosmetic, AntiHistamine, Anti Protozoal, Dental Cure, Anti Parasitic etc. 
  • The company has 43 third party manufacturers for its drugs across states like Gujarat, Maharashtra, Punjab, Himachal Pradesh, Haryana, Madhya Pradesh, Uttarakhand etc. 
  • Sunrise Lifescience has a total of 32 products and 18  registered trademarks.

CONS

  • The company works in a highly competitive segment.

Sunrest Lifescience Limited IPO Application Process with Zerodha

It is very easy to apply for an IPO now if you have a DEMAT account with Zerodha. Follow the steps below for the same :

  1.   Logging into Zerodha console through its website or KITE platform. Clicking the IPO section present in the ORDER tab.
  2.   Click the Sunrest Lifescience Limited IPO button and press the BID button.
  3.   Entering the details asked for like UPI ID, Quantity and price.
  4.   Submit the application form for the IPO.
  5. Visiting the application of UPI for approving the transaction.

Now, applying for an IPO online is possible with most of the Discount and online brokers.

Looking for Best Stock Broker in India?

we will help you to find best broker with Free demat & lowest brokerage